Metraipolis › archive › dc_21bc9c04cdfe
Progress of Immunotherapies in Parkinson's Disease — Europe PMC PMID:42227981
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42227981
- DOI
- 10.1002/cns.70964
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-01T01:50:54.881Z
- SHA-256 of the archived text
3034e9e72045613520c541dae2211b29f238bedf8219a6751dda66d43b342841- Stable URL of this page
https://metraipolis.com/documento/dc_21bc9c04cdfe
How to cite
Progress of Immunotherapies in Parkinson's Disease — Europe PMC PMID:42227981 — Europe PMC (en), https://europepmc.org/article/MED/42227981 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_21bc9c04cdfe (Metraipolis archive dc_21bc9c04cdfe, sha256 3034e9e72045613520c541dae2211b29f238bedf8219a6751dda66d43b342841)
BibTeX
@misc{dc21bc9c04cdfe,
title = {Progress of Immunotherapies in Parkinson's Disease — Europe PMC PMID:42227981},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42227981},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_21bc9c04cdfe; sha256 3034e9e72045613520c541dae2211b29f238bedf8219a6751dda66d43b342841},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42227981. Agents can read the archived copy with the MCP tool read_document.